Clinical Trials
260 trialsVESTI
Aalto University
FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma
FluoGuide A/S
Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer
Alliance for Clinical Trials in Oncology
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Peds IMPACT
University of Florida
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
NOVA-GBM
Myosin Therapeutics Inc.
FET-BRAIN-DX
IRCCS San Raffaele
PIRe
Rigshospitalet, Denmark
VBS-CSI-PT-PED
Ruijin Hospital
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Washington University School of Medicine
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
M.D. Anderson Cancer Center
Gait in Young Children With NF1
NYU Langone Health
EViDENCE-BT
University of Zurich
SHAM INDYGO/DO
University Hospital, Lille
IMPACT MET
University of Florida
APATC
Center Eugene Marquis
BALANCE
Duke University
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals
MELODY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
NRG Oncology
MRinRT
Swansea Bay University Health Board
FCI-Glioblastoma Study
University of Aberdeen
Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases
Nanfang Hospital, Southern Medical University
REVIIH-BT
Institut National de la Santé Et de la Recherche Médicale, France
BRiTE
Duke University
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
University of Alabama at Birmingham
PRRT-PGL-PHEO
Azienda USL Reggio Emilia - IRCCS
Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
T-BRAIN
Maastricht University Medical Center
STARGATE
University Hospital, Essen
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
University of Iowa
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
The Second Affiliated Hospital of Hainan Medical University
Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5
Shaare Zedek Medical Center
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Jazz Pharmaceuticals
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
APT-HGG
IRCCS Ospedale San Raffaele
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
M.D. Anderson Cancer Center
Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases
Shanghai Changzheng Hospital
The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
Shanghai Changzheng Hospital
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases
National Taiwan University Hospital
NF118
University of Alabama at Birmingham
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
Beijing Tiantan Hospital
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Nationwide Children's Hospital
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Case Comprehensive Cancer Center
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
ThINKK-01
St. Justine's Hospital